NEW YORK — Inc. magazine recently ranked Spine & Sport of Savannah No. 357 on its 28th annual Inc. 500, a ranking of the nation’s fastest-growing private companies.
The list offers a look at America’s independent-minded entrepreneurs. Companies such as Microsoft, Zappos, Intuit, GoDaddy, Under Armour, Jamba Juice, American Apparel and Oracle gained early exposure as members of the Inc. 500.
“If you want to know which companies are going to change the world, look at the Inc. 500,” said Inc. editor Jane Berentson. “These are the most dynamic, fast-growth companies in the nation, the ones finding innovative solutions to problems, creating smart systems, and inventing products we soon discover we can’t live without. The Inc. 500 list is Inc. magazine’s tribute to American business ingenuity and ambition.”
Spine & Sport was founded in 2004 by Dr. Jacques L. Beauchamp and Dr. Eric C. Bull. The company specializes in the advanced practice of physical therapy and personal training services. It has grown from a one-room clinic with three employees to six facilities employing more than 100 staff members in four years. Spine & Sport currently serves southeast Georgia with clinics in downtown Savannah, Wilmington Island, Effingham, Richmond Hill and Hinesville.
The 2009 Inc. 500, unveiled in the September issue of the magazine, reported aggregate revenue of $18.4 billion — up significantly from last year’s $13.7 billion — and a median three-year growth rate of 880.5 percent. The companies on this year’s list are also responsible for creating more than 55,000 jobs since their founding.
The largest company on the list, flat-panel-TV maker Vizio, broke the $2 billion revenue mark. Complete results of the Inc. 500, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on Inc.com.
Despite the ongoing recession, the 2009 Inc. 500 offers a glimpse of the future of the U.S. economy. In the health sector, which saw aggregate revenue of $1.1 billion and a 917 percent median growth rate, businesses are moving forward on cancer and stem-cell research, clinical trials, and medication management.
The list offers a look at America’s independent-minded entrepreneurs. Companies such as Microsoft, Zappos, Intuit, GoDaddy, Under Armour, Jamba Juice, American Apparel and Oracle gained early exposure as members of the Inc. 500.
“If you want to know which companies are going to change the world, look at the Inc. 500,” said Inc. editor Jane Berentson. “These are the most dynamic, fast-growth companies in the nation, the ones finding innovative solutions to problems, creating smart systems, and inventing products we soon discover we can’t live without. The Inc. 500 list is Inc. magazine’s tribute to American business ingenuity and ambition.”
Spine & Sport was founded in 2004 by Dr. Jacques L. Beauchamp and Dr. Eric C. Bull. The company specializes in the advanced practice of physical therapy and personal training services. It has grown from a one-room clinic with three employees to six facilities employing more than 100 staff members in four years. Spine & Sport currently serves southeast Georgia with clinics in downtown Savannah, Wilmington Island, Effingham, Richmond Hill and Hinesville.
The 2009 Inc. 500, unveiled in the September issue of the magazine, reported aggregate revenue of $18.4 billion — up significantly from last year’s $13.7 billion — and a median three-year growth rate of 880.5 percent. The companies on this year’s list are also responsible for creating more than 55,000 jobs since their founding.
The largest company on the list, flat-panel-TV maker Vizio, broke the $2 billion revenue mark. Complete results of the Inc. 500, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on Inc.com.
Despite the ongoing recession, the 2009 Inc. 500 offers a glimpse of the future of the U.S. economy. In the health sector, which saw aggregate revenue of $1.1 billion and a 917 percent median growth rate, businesses are moving forward on cancer and stem-cell research, clinical trials, and medication management.